Edit |   |
---|---|
Antigenic Specificity | Lipoteichoic Acid, Staphylococcus epidermidis (Pagibaximab biosimilar) |
Clone | Pagibaximab |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FuncS, IF, Neut, ELISA, FCM, IP |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody. Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010, it is undergoing Phase II/III clinical trials. |
Immunogen | n/a |
Other Names | Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab, Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody, BSYX-A110, PMAB, Antibody Drug Analogues, Monoclonal Antibody, YR1165, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 595566-61-3 |
Catalog # | YR1165 |
Price | please inquire |
Order / More Info | Lipoteichoic Acid, Staphylococcus epidermidis (Pagibaximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |